Dr. Howard David Pettigrew, MD, PhD

Dr. Pettigrew practices at Baz Allergy, Asthma & Sinus Center, Inc. in Fresno, California.

Dr. Pettigrew's NPI, 1891961835, was assigned on April 30, 2008. Dr. Pettigrew graduated from The Robert Larner, M.D. College of Medicine in 2004. Dr. Pettigrew holds California license A104136.

Dr. Pettigrew's primary practice is Baz Allergy, Asthma & Sinus Center, Inc., at 7471 N Fresno St, Fresno, CA 93720 in Fresno County. The practice phone is (559) 981-5040.

Dr. Pettigrew's primary practice is Baz Allergy, Asthma & Sinus Center, Inc. in Fresno, California. Dr. Pettigrew is also affiliated with Community Regional Medical Center. The medical group on file is Baz Allergy, Asthma & Sinus Center. Dmand AI also links Dr. Pettigrew to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Pettigrew practices, 4 sites in all. Vendor and product names are available with a free account.

Allergy is Dr. Pettigrew's primary specialty in the NPI Registry, under taxonomy code 207KA0200X. Dmand AI has Dr. Pettigrew's licenses on file in 2 states: California and Pennsylvania.

Dmand AI lists asthma and chronic nasal allergies among the conditions Dr. Pettigrew treats.

CMS data shows 16,910 Medicare services from Dr. Pettigrew across 14 procedure codes in 2024, for 505 Medicare patients. Medicare paid $226,966 for them. Every service was in an office.

CMS counts 505 Medicare patients who saw Dr. Pettigrew in 2024. The largest group is 65 to 74, with 243 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 34% are also on Medicaid. Their average risk score is 1.06, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Pettigrew's median patient age at 28, with 58% women.

In 2024, Dr. Pettigrew wrote 1,967 Medicare Part D claims for 500 patients. 67% of them were for generic drugs. CMS names the drug for 1,865 of them, across 27 drugs with 11 or more claims each, at $273,494 in total drug cost. In 2023, CMS named 838 claims across 18 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Pettigrew for performance year 2024, reported as part of a group. Dr. Pettigrew accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 4 papers to Dr. Pettigrew. Dr. Pettigrew has published most often in Clin Rev Allergy Immunol. Dr. Pettigrew's most frequent co-authors are Suzanne S. Teuber, MD and James S. Kong, MD.

CMS Open Payments shows 180 general payments to Dr. Pettigrew from 23 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 96% of the total. BioCryst Pharmaceuticals, Inc. paid the most, $539.

Dmand AI lists 1 award for Dr. Pettigrew, most recently CMS Stage 1 2012 in 2012.

Dr. Pettigrew graduated from The Robert Larner, M.D. College of Medicine in 2004. Dr. Pettigrew is a member of AAAAI.

Dr. Pettigrew is in network with 15 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.